161 related articles for article (PubMed ID: 32657203)
1. Synthesis and structure-activity relationships of cerebroside analogues as substrates of cerebroside sulphotransferase and discovery of a competitive inhibitor.
Li W; Guillaume J; Baqi Y; Wachsmann I; Gieselmann V; Van Calenbergh S; Müller CE
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1503-1512. PubMed ID: 32657203
[TBL] [Abstract][Full Text] [Related]
2. A capillary electrophoresis method with dynamic pH junction stacking for the monitoring of cerebroside sulfotransferase.
Li W; Zech I; Gieselmann V; Müller CE
J Chromatogr A; 2015 Aug; 1407():222-7. PubMed ID: 26163931
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive review on structural and therapeutical insight of Cerebroside sulfotransferase (CST) - An important target for development of substrate reduction therapy against metachromatic leukodystrophy.
Singh N; Singh AK
Int J Biol Macromol; 2024 Feb; 258(Pt 1):128780. PubMed ID: 38104688
[TBL] [Abstract][Full Text] [Related]
4. Metachromatic leukodystrophy (MLD) in hospitalized adult schizophrenic patients resistant to drug treatment.
Galbraith DA; Gordon BA; Feleki V; Gordon N; Cooper AJ
Can J Psychiatry; 1989 May; 34(4):299-302. PubMed ID: 2567620
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of metachromatic leukodystrophy, Krabbe disease, and Farber disease after uptake of fatty acid-labeled cerebroside sulfate into cultured skin fibroblasts.
Kudoh T; Wenger DA
J Clin Invest; 1982 Jul; 70(1):89-97. PubMed ID: 6806321
[TBL] [Abstract][Full Text] [Related]
6. Presymptomatic diagnosis: metachromatic leukodystrophy or pseudo arylsulphatase A deficiency?
Kihara H; Fluharty AL; Ng WG; Leider W
J Inherit Metab Dis; 1982; 5(4):215-7. PubMed ID: 6133034
[TBL] [Abstract][Full Text] [Related]
7. Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.
Babcock MC; Mikulka CR; Wang B; Chandriani S; Chandra S; Xu Y; Webster K; Feng Y; Nelvagal HR; Giaramita A; Yip BK; Lo M; Jiang X; Chao Q; Woloszynek JC; Shen Y; Bhagwat S; Sands MS; Crawford BE
Sci Rep; 2021 Jul; 11(1):14486. PubMed ID: 34262084
[TBL] [Abstract][Full Text] [Related]
8. Metachromatic leukodystrophy: consequences of sulphatide accumulation.
Gieselmann V; Franken S; Klein D; Mansson JE; Sandhoff R; Lüllmann Rauch R; Hartmann D; Saravanan VP; De Deyn PP; D'Hooge R; Van Der Linden AM; Schaeren-Wiemers N
Acta Paediatr Suppl; 2003 Dec; 92(443):74-9; discussion 45. PubMed ID: 14989469
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of pyrene derivatives of cerebroside sulfate and their use for determining arylsulfatase A activity.
Marchesini S; Viani P; Cestaro B; Gatt S
Biochim Biophys Acta; 1989 Mar; 1002(1):14-9. PubMed ID: 2564282
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetics of metachromatic leukodystrophy.
Gieselmann V; Polten A; Kreysing J; von Figura K
J Inherit Metab Dis; 1994; 17(4):500-9. PubMed ID: 7967499
[TBL] [Abstract][Full Text] [Related]
11. Restoration of arylsulphatase A activity in human-metachromatic-leucodystrophy fibroblasts via retroviral-vector-mediated gene transfer.
Rommerskirch W; Fluharty AL; Peters C; von Figura K; Gieselmann V
Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):459-61. PubMed ID: 1684103
[TBL] [Abstract][Full Text] [Related]
12. Identification of a new Arylsulfatase A (ARSA) gene mutation in Tunisian patients with metachromatic leukodystrophy (MLD).
Dorboz I; Eymard-Pierre E; Kefi R; Abdelhak S; Miladi N; Boespflug-Tanguy O;
J Neurol Sci; 2009 Dec; 287(1-2):278-80. PubMed ID: 19699491
[TBL] [Abstract][Full Text] [Related]
13. Bile salt activation of cerebroside sulphate sulphohydrolase.
Fluharty AL; Stevens RL; Miller RT; Kihara H
Biochem J; 1980 Jul; 189(1):45-9. PubMed ID: 6109529
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in the biochemistry of globoid and metachromatic leucodystrophies.
Farooqui AA; Mandel P
Biomedicine; 1977 Jul; 26(4):232-6. PubMed ID: 21709
[TBL] [Abstract][Full Text] [Related]
15. Cerebroside sulfatase activator deficiency induced metachromatic leukodystrophy.
Stevens RL; Fluharty AL; Kihara H; Kaback MM; Shapiro LJ; Marsh B; Sandhoff K; Fischer G
Am J Hum Genet; 1981 Nov; 33(6):900-6. PubMed ID: 6119902
[TBL] [Abstract][Full Text] [Related]
16. Genetic complementation in somatic cell hybrids of cerebroside sulfatase activator deficiency and metachromatic leukodystrophy fibroblasts.
Kihara H; Tsay KK; Fluharty AL
Hum Genet; 1984; 66(4):300-1. PubMed ID: 6144627
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of cerebroside sulfate and subcellular distribution of its metabolites in cultured skin fibroblasts from controls, metachromatic leukodystrophy, and globoid cell leukodystrophy.
Inui K; Furukawa M; Okada S; Yabuuchi H
J Clin Invest; 1988 Feb; 81(2):310-7. PubMed ID: 3339122
[TBL] [Abstract][Full Text] [Related]
18. Impaired cerebroside sulfate hydrolysis in fibroblasts of sibs with "pseudo" arylsulfatase A deficiency without metachromatic leukodystrophy.
Hreidarsson SJ; Thomas GH; Kihara H; Fluharty AL; Kolodny EH; Moser HW; Reynolds LW
Pediatr Res; 1983 Sep; 17(9):701-4. PubMed ID: 6137805
[TBL] [Abstract][Full Text] [Related]
19. Metachromatic leukodystrophy: molecular genetics and an animal model.
Gieselmann V; Matzner U; Hess B; Lüllmann-Rauch R; Coenen R; Hartmann D; D'Hooge R; DeDeyn P; Nagels G
J Inherit Metab Dis; 1998 Aug; 21(5):564-74. PubMed ID: 9728336
[TBL] [Abstract][Full Text] [Related]
20. The activator of cerebroside-sulphatase. A model of the activation.
Fischer G; Jatzkewitz H
Biochim Biophys Acta; 1978 Jan; 528(1):69-76. PubMed ID: 23173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
